Alexander Dobrovic

Credit Name
Alexander Dobrovic
Full Name
Dobrovic, Alexander
 
 
Twitter
Loading... 2 0 20 0 false
Loading... 3 0 20 0 false

Publications

Refined By:
Author:  Cebon, Jonathan S
Date Issued:  [2010 TO 2019]

Results 1-6 of 6 (Search time: 0.004 seconds).

Publication YearTitleAuthor(s)
1May-2019Genomic Analysis of Circulating Tumor DNA Using a Melanoma-Specific UltraSEEK Oncogene Panel.Gray, Elin S; Witkowski, Tom ; Pereira, Michelle; Calapre, Leslie; Herron, Karl; Irwin, Darryl; Chapman, Brett; Khattak, Muhammad A; Raleigh, Jeanette; Hatzimihalis, Athena; Cebon, Jonathan S ; Sandhu, Shahneen; McArthur, Grant A; Millward, Michael; Ziman, Melanie; Dobrovic, Alexander ; Wong, Stephen Q
224-Apr-2019BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival.Lee, Erinna F; Harris, Tiffany J ; Tran, Sharon; Evangelista, Marco; Arulananda, Surein; John, Thomas ; Ramnac, Celeste; Hobbs, Chloe; Zhu, Haoran; Gunasingh, Gency; Segal, David; Behren, Andreas; Cebon, Jonathan S ; Dobrovic, Alexander ; Mariadason, John M ; Strasser, Andreas; Rohrbeck, Leona; Haass, Nikolas K; Herold, Marco J; Fairlie, W Douglas
322-Jun-2015Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations.Tsao, Simon Chang-Hao; Weiss, Jonathan; Hudson, Christopher; Christophi, Christopher ; Cebon, Jonathan S ; Behren, Andreas; Dobrovic, Alexander 
420-Jan-2015Whole exome sequencing identifies a recurrent RQCD1 P131L mutation in cutaneous melanoma.Wong, Stephen Q; Behren, Andreas; Mar, Victoria J; Woods, Katherine; Li, Jason; Sheppard, Karen E; Wolfe, Rory; Kelly, John; Cebon, Jonathan S ; Dobrovic, Alexander ; McArthur, Grant A
54-Nov-2013BRAF inhibitor-driven tumor proliferation in a KRAS-mutated colon carcinoma is not overcome by MEK1/2 inhibition.Andrews, Miles C; Behren, Andreas; Chionh, Fiona; Mariadason, John M ; Vella, Laura J; Do, Hongdo; Dobrovic, Alexander ; Tebbutt, Niall C ; Cebon, Jonathan S 
611-Oct-2013Intratumoral genetic heterogeneity in metastatic melanoma is accompanied by variation in malignant behaviors.Anaka, Matthew; Hudson, Christopher; Lo, Pu-Han; Do, Hongdo; Caballero, Otavia L; Davis, Ian D; Dobrovic, Alexander ; Cebon, Jonathan S ; Behren, Andreas